EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSLACG00000006400
Gene Symbol: RARB
3 Cross references
449 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSLACG00000016217
Gene Symbol: RARG
2 Cross references
449 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSLACG00000018765
Gene Symbol: RXRA
2 Cross references
248 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSLACG00000006999
Gene Symbol: RXRB
4 Cross references
234 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSLACG00000005442
Gene Symbol: RPL10
4 Cross references
410 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSLACG00000010502
Gene Symbol: RPL11
4 Cross references
287 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSLACG00000015373
Gene Symbol: RPL12
4 Cross references
454 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSLACG00000013768
Gene Symbol: RPL13
4 Cross references
269 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSLACG00000019092
Gene Symbol: RPL13A
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSLACG00000015639
Gene Symbol: RPL14
1 Cross references
267 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSLACG00000001914
Gene Symbol: RPL15
4 Cross references
370 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSLACG00000008835
Gene Symbol: RPL17
4 Cross references
711 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).